Earnings Feed
Start Free
Home/Filings/4/0000313143-13-000194
4//SEC Filing

HAEMONETICS CORP 4

Accession 0000313143-13-000194

$HAECIK 0000313143operating
View on SEC.govCompany Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 5:48 PM ET

Size

24.4 KB

Accession

0000313143-13-000194

Insider Transaction Report

Form 4
Period: 2013-11-11
HAEMONETICS CORPHAE
Kelly Michael P
President, NA, Global Plasma
Transactions
  • Sale

    Common Stock

    2013-11-11$39.70/sh−18,660$740,819→ 10,987 total
  • Sale

    Common Stock

    2013-11-11$39.70/sh−30,104$1,195,156→ 10,987 total
  • Exercise/Conversion

    Common Stock

    2013-11-12$27.48/sh+2,800$76,958→ 13,787 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2013-11-11$39.70/sh−30,104$1,195,156→ 19,836 total
    Exercise: $27.48From: 2011-07-28Exp: 2017-07-28→ Common Stock (30,104 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2013-11-11$39.70/sh−18,660$740,819→ 18,666 total
    Exercise: $30.67From: 2012-10-25Exp: 2018-10-25→ Common Stock (18,660 underlying)
  • Sale

    Common Stock

    2013-11-11$39.70/sh−9,836$390,498→ 10,987 total
  • Sale

    Common Stock

    2013-11-12$39.66/sh−2,800$111,051→ 10,987 total
  • Exercise/Conversion

    Common Stock

    2013-11-11$39.05/sh+9,836$384,145→ 20,823 total
  • Exercise/Conversion

    Common Stock

    2013-11-11$30.67/sh+18,660$572,302→ 29,647 total
  • Exercise/Conversion

    Common Stock

    2013-11-11$27.48/sh+30,104$827,408→ 41,091 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2013-11-12$39.66/sh−2,800$111,051→ 17,036 total
    Exercise: $27.48From: 2011-07-28Exp: 2017-07-28→ Common Stock (2,800 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2013-11-11$39.70/sh−9,836$390,498→ 29,508 total
    Exercise: $39.05From: 2013-10-24Exp: 2019-10-24→ Common Stock (9,836 underlying)
Holdings

  • Performance Shares

    Exercise: $0.00From: 2027-03-31Exp: 2027-03-31→ Common Stock (25,000 underlying)
    25,000
Footnotes (2)
  • [F1]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
  • [F2]Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).

Documents

1 file

Issuer

HAEMONETICS CORP

CIK 0000313143

→
Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000313143

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:48 PM ET
Size
24.4 KB
View on SEC.gov